New York Life Investment Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.1M Buy
40,257
+5,818
+17% +$349K 0.02% 533
2025
Q4
$2.03M Sell
34,439
-2,390
-6% -$145K 0.02% 522
2025
Q3
$2.05M Sell
36,829
-651
-2% -$34.9K 0.02% 541
2025
Q2
$1.93M Sell
37,480
-276
-0.7% -$13.9K 0.02% 542
2025
Q1
$2.21M Sell
37,756
-776
-2% -$52.6K 0.02% 516
2024
Q4
$2.78M Buy
38,532
+4
+0% +$294 0.03% 473
2024
Q3
$3.08M Sell
38,528
-2,484
-6% -$187K 0.03% 472
2024
Q2
$2.94M Buy
41,012
+1,694
+4% +$125K 0.03% 453
2024
Q1
$2.77M Sell
39,318
-1,396
-3% -$99.9K 0.03% 476
2023
Q4
$3.14M Buy
40,714
+1,121
+3% +$73.8K 0.03% 421
2023
Q3
$2.7M Buy
39,593
+8,601
+28% +$679K 0.03% 431
2023
Q2
$2.53M Buy
30,992
+7,516
+32% +$604K 0.03% 454
2023
Q1
$1.74M Buy
23,476
+426
+2% +$32.8K 0.02% 535
2022
Q4
$1.91M Buy
23,050
+342
+2% +$27.2K 0.02% 525
2022
Q3
$1.61M Buy
22,708
+24
+0.1% +$2.07K 0.02% 556
2022
Q2
$1.97M Buy
+22,684
New +$2.13M 0.02% 518

Other funds holding TECH

New York Life Investment Management's TECH Position: Q1 2026 in Review

New York Life Investment Management increased its Bio-Techne (TECH) stake by 17% in Q1 2026, buying an estimated $349K and bringing the position to 40,257 shares worth $2.1M. The position accounts for 0.02% of the portfolio, ranked #533.

New York Life Investment Management first reported a position in TECH in Q2 2022 and has held it in 16 quarters since. The position peaked at $3.14M in Q4 2023. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • New York Life Investment Management held 40,257 shares of Bio-Techne worth $2.1M as of Q1 2026.
  • New York Life Investment Management bought 5,818 Bio-Techne shares in Q1 2026, an estimated $349K.
  • Bio-Techne made up 0.02% of New York Life Investment Management's portfolio in Q1 2026, its #533 holding.
  • New York Life Investment Management first reported a position in Bio-Techne in Q2 2022 and has held it in 16 quarters since.
  • New York Life Investment Management's Bio-Techne position peaked at $3.14M in Q4 2023.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.